Hubei Clinical Center and Key Laboratory for Intestinal and Colorectal Diseases, Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Eur J Gastroenterol Hepatol. 2024 Feb 1;36(2):229-237. doi: 10.1097/MEG.0000000000002696. Epub 2023 Dec 10.
This meta-analysis was designed to evaluate the clinical outcomes of transjugular intrahepatic portosystemic shunt (TIPS) conducted utilizing stents of different diameters, thus providing recommendations for more logical selections of covered stents for patients with portal hypertension, in particular for the Asian population.
Web of Science, PubMed, Embase, Cochrane Library, Chinese National Knowledge Infrastructure and Wan Fang were searched for randomized controlled trials and cohort studies from inception until February 2023. The meta-analysis was carried out using Revman 5.4 Software. Heterogeneity between researches was assessed by the χ2 test and I2 index. The outcomes evaluated were the incidence of post-TIPS hepatic encephalopathy (HE), variceal rebleeding, shunt dysfunction, 1-year overall survival and decrease in portal pressure gradient (PPG).
Eight appropriate clinical trials with 1246 patients were selected (638 and 608 patients in the experimental and control groups, respectively). In regards to preoperative PPG reduction, there was no discernible difference between the two groups [mean difference = 1.15, 95% confidence interval (CI) = -0.29-2.58, P = 0.12]. The rate of post-TIPS HE was significantly higher in patients in the 8 mm stent group than in the 6-7 mm stent group [odds ratio (OR) = 0.54, 95% CI = 0.42-0.70, P < 0.00001, I2 = 46%]. There were no significant differences in the rates of variceal rebleeding (OR = 1.05, 95% CI = 0.67-1.65, P = 0.84, I2 = 0%), shunt dysfunction (OR = 0.88, 95% CI = 0.53-1.47, P = 0.64, I2 = 0%) and 1-year overall survival (OR = 0.86, 95% CI = 0.50-1.50, P = 0.61, I2 = 0%).
Asian populations with portal hypertension may benefit more from TIPS with 6-7 mm covered stents because they can reduce the risk of postoperative HE while offering similar efficacy when compared to 8 mm covered stents.
本荟萃分析旨在评估不同直径支架经颈静脉肝内门体分流术(TIPS)的临床疗效,为门脉高压患者,特别是亚洲人群选择覆膜支架提供更合理的建议。
计算机检索 Web of Science、PubMed、Embase、Cochrane Library、中国知网和万方数据库,搜集建库至 2023 年 2 月关于不同直径支架 TIPS 治疗的随机对照试验和队列研究。采用 RevMan 5.4 软件进行荟萃分析。采用 χ 2 检验和 I 2 指数评估研究间的异质性。评估指标包括 TIPS 术后肝性脑病(HE)、静脉曲张再出血、分流道功能障碍、1 年总生存率和门静脉压力梯度(PPG)下降发生率。
最终纳入 8 项合适的临床试验,共 1246 例患者(实验组和对照组分别为 638 例和 608 例)。术前 PPG 降低方面,两组间差异无统计学意义[平均差值=1.15,95%置信区间(CI)=-0.29-2.58,P=0.12]。8mm 支架组 TIPS 术后 HE 发生率明显高于 6-7mm 支架组[比值比(OR)=0.54,95%CI=0.42-0.70,P<0.00001,I 2 =46%]。两组静脉曲张再出血(OR=1.05,95%CI=0.67-1.65,P=0.84,I 2 =0%)、分流道功能障碍(OR=0.88,95%CI=0.53-1.47,P=0.64,I 2 =0%)和 1 年总生存率(OR=0.86,95%CI=0.50-1.50,P=0.61,I 2 =0%)差异均无统计学意义。
对于亚洲门静脉高压患者,6-7mm 覆膜支架 TIPS 可能更有益,因为与 8mm 覆膜支架相比,其可降低术后 HE 风险,同时疗效相当。